Phoenix Life Sciences International

About:

Phoenix Life Sciences International Limited is an adaptive healthcare solutions company.

Website: http://www.phoenixlife.co

Twitter/X: PhoenixLifeSci1

Description:

Phoenix Life Sciences International is a global platform for the re-introduction of organic, plant-based pharmaceuticals and programs for creating healthcare solutions and reducing total cost of national healthcare programs Their business is to advance research and integrate programs and manufacturing of products that target and treat; diabetes, pain, cancers, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. Phoenix Life Sciences creating partnerships for integrating these programs for human health into communities worldwide as part of their Global Health Initiative. Working with developing nations on programs to improve affordable healthcare and creating industry. Phoenix Life Sciences uses organically produced plants, including cannabis, extracts the purest of active ingredients, and encapsulates them for maximum bioavailability and efficacy. Providing a patient-centric alternative to the low efficacy and the high side effects of conventional pharmaceuticals.

Total Funding Amount:

$1.01M

Headquarters Location:

Denver, Colorado, United States

Founded Date:

2013-01-01

Contact Email:

investor.relations(AT)phoenixlife.co

Founders:

Martin Tindall

Number of Employees:

1-10

Last Funding Date:

2018-11-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai